
Compounds demonstrate high cancer-killing activity and low-toxicity in non-tumor cell line.

Compounds demonstrate high cancer-killing activity and low-toxicity in non-tumor cell line.

A mother’s immune response to anti-herpes simplex virus-2 may disrupt development of fetal central nervous system.

Targeted and individualized breast cancer treatment is viable.

Long-term metformin therapy associated with lower serum vitamin B12 concentration.

Children with the C9orf72 mutation are affected with these diseases at a younger age than the parent.

Medical providers with a tendency to order more tests and treatments influence how the health of a population is measured.

Top news of the day from across the health care landscape.

Adjuvant bleomycin, etoposide, and cisplatin shows promise treating testicular cancer.

Many patients with stage 1 and 2 breast cancer are administered aggressive chemotherapy.

Manufacturers say they are unable to lower the cost of some drugs due to pharmacy benefit manager involvement.

The challenges of living a normal, active life while managing multiple sclerosis.

Combination therapy may improve treatment strategies for hepatocellular carcinoma.

Scientists continue to pursue the development of an HIV cure.

New treatment approach harnesses the abilty of liver cells to burn accumulated fats.

Promise seen in targeting protein in PTEN-deficient cancer cells.

Marc O'Connor, COO and chief strategy officer for Curant Health, discusses how specialty pharmacies can demonstrate value as the use of value-based care designs increase.

Updates on the national performance benchmarks for digital mammography.

Top news of the day from across the health care landscape.

Some aspects of the ACA will remain, others are on the chopping block.

The focus on specialty drug development and approvals have raised questions as to whether traditional pharmacy was being replaced by specialty pharmacy.

Synovial CD4+ T cells that produce IL-21 play a role in joint inflammation.

Erin Hohman, PharmD, BCPS, director of Clinical Pharmacy Services at Amber Pharmacy, discusses utilization management issues with a PCSK9 inhibitor regimen for high cholesterol.

Prostate cancer can be subtyped based on cell of origin as luminal A, luminal B, and basal cell subtypes.

Treatment shows benefit in patients with low-grade serous cancer.

Top news of the day from across the health care landscape.

Specialty pharmacies are poised to fill a need in health care should the use of Health Savings Accounts grow.

Atopic dermatitis drug improves overall disease severity in phase 3 clinical trial.

Early-stage breast cancer patients with low muscle quality and quantity have twice the risk of hospitalization.

Treatment with the myxoma virus reduced tumor burden and led to a modest decrease in disease progression in mice.

Diseases such as multiple sclerosis, lupus, and psoriasis showed a statistically significant association with dementia.